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Abstract 
 
OBJECTIVE: The objective if this systematic review is to determine whether or not cardiac 
resynchronization therapy with aerobic exercise improves exercise tolerance / ability better then either 
treatment alone or no intervention at all. 
 
 
STUDY DESIGN: Review of 4 English language primary studies. 2 Investigator Blinded and 2 Double 
Blind Crossover studies were used. 
 
 
DATA  SOURCES: Articles were found utilizing OVID and COCHRANE databases. 
 
 
OUTCOME MEASURED: 4 outcomes were considered in this review. Dyspnea, leg comfort, exercise 
time / AT, and V02 (exercise tolerance).  
 
 
RESULTS: The Wasserman article concludes that those indivduals who are beginning with a baseline 
Peak V02 of < 50% of predicted benefit greatly from BVP-ON w/exercise while those with BVP-OFF 
or BVP-ON (Peak V02 > 50% predicted) show no statistically significant different. The Laveneziana 
article concludes patients with CRT-ON during exercise showed marked improvement in dyspnea and 
leg discomfort (typically leg discomfort is seen as the major limiting symptom in patients with CHF [as 
seen in this study]). The Schlosshan article concludes that CRT in long term therapy (post remodeling) 
continues to confer benefit to the heart. The Conraads article concludes that the  combination of CRT 
with endurance training show a synergistic effect on exercise tolerance (better then either alone). 
 
 
CONCLUSION: The results of all 4 articles express similar conclusion. Exercise and CRT therapy are 
both beneficial on exercise tolerance and perhaps even reduction of cardiac remodeling. However, 
Exercise with CRT therapy provides benefit beyond either therapy alone. 
 
 
KEY WORDS: CRT (cardiac resynchronization therapy), LVEF (left ventricular ejection fraction), 
peak VO2, NYHA (new york heart association), BVP (bi-ventricular pacing), CHF (congestive heart 
failure), CPET (cardiopulmonary exercise testing), LVF (left ventricular failure), AT (anaerobic 
threshold). 
INTRODUCTION 
 Congestive heart failure is a condition where the heart is no long able to pump an adequate 
amount of blood throughout the body. It affects millions of people world wide. CHF is more prevelant 
with age which makes it an increasingly important issue as our aged population continues to enlarge. 
There are many causes such as coronary artery disease, HTN or any condition that alters / damages 
heart tissue (MI, viruses, toxic exposures). There are different types of heart failure: systolic 
dysfunction, diastolic dysfunction. Systolic function involves impairment in heart contraction such as 
in a dilated cardiomyopathy. Diastolic dysfunction involves impairment in ventricle filling such as in a 
ventricular hypertrophy. CHF can be classified according to symptoms experienced during everyday 
activities using the New York Heart Association classification.  
Table 1: NYHA Classifications 
NYHA Class Symptoms 
I 
No symptoms and no limitation in ordinary 
physical activity, e.g. shortness of breath 
when walking, climbing stairs etc. 
II 
Mild symptoms (mild shortness of breath 
and/or angina) and slight limitation during 
ordinary activity. 
III 
Marked limitation in activity due to symptoms, 
even during less-than-ordinary activity, e.g. 
walking short distances (20–100 m). 
Comfortable only at rest. 
IV 
Severe limitations. Experiences symptoms 
even while at rest. Mostly bedbound patients. 
  
 There are many signs and symptoms of congestive heart failure. There are non side specific 
symptoms such as tachycardia, hypotension, diaphoresis, cachexia, cyanosis, clubbing. There are left 
sided heart failure signs and symptoms such as shortness of breath, orthopnea, chronic non-productive 
cough and exercise intolerance. There are right sided heart failure signs and symptoms such as loss of 
appetite, (pitting) edema, ascites, nausea, jugular venus pressure increse, hepatic enlargment. It is 
important to remember that most patients suffer a combination of both left and right sided heart failure 
with one predominating. Right sided heart failure is most commonly caused by left sided heart failure.  
 Diagnoses can be made by analyzing multiple areas of health: CBC, renal function tests, BNP, 
EKG, chest radiography, echo cardiography , angiography and cardiac catheterization. While there are 
multiple avenues for diagnosing; effective treatments / cures still elude us. There are a multitude of 
both pharmacological and non-pharmacological treatments. The current standard medicines are 
diuretics, ACE inhibitors, ARB's, beta blockers, digitalis, nitrates, neseritide and hydralazine. Other 
pharmacological treatments include inotropic agents, antiarhythmics, statins, anticoagulation and 
CCB's. Non-pharmacological treatments involve revascularization, cardiac transplant, diet, exercise 
and pacing. Exercise and ventricular pacing our the focus of this paper. The importance of research and 
evidence based treatments can be seen in the sequelae of congestive heart failure: organ failure (kidney 
/ liver), pulmonary edema, decrease in physical capacity and death. 
 Physician assistants are highly valued instruments in the care of CHF patients. CHF is a non-
reversible disease that requires enormous amounts of care and money. PA's, rather then doctors, are 
able to spend longer periods of time with patients aiding them in understanding their disease and 
employing treatments that are best suited to them at a lower cost. The treatments highlighted in this 
paper are time consuming and require discipline, however as you will see in this paper are effective. 
OBJECTIVE 
 The objective if this systematic review is to determine whether or not cardiac resynchronization 
therapy with aerobic exercise improves exercise tolerance / ability better then either treatment alone or 
no intervention at all. The hypothesis is that the above two treatments do indeed improve exercise 
tolerance better then either treatment alone or not at all. 
METHODS 
 All 4 studies met the following criteria for population selection. Patients were aged 50-80 with a 
NYHA class II or greater. Left ventricular ejection fraction (LVEF) was < 35% in all selected patients 
and the QRS complex width was > 120ms. Two of the studies were investigator blinded [Wasserman, 
Conraads] and 2 of the studies were double blind crossover studies [Laveneziana. Schlosshan] 
 The general interventions were CRT on or off during aerobic exercise. Essentially pts with CRT 
on during exercise were compared to patients with CRT off during exercise. In one experiment CRT 
with exercise is compared to CRT alone [Conraads]. Four questions were analyzed to determine 
treatment outcome. Do patients feel exercise tolerance is improved? Do patients experience less 
dyspnea? Do patients experence less leg pain? Peak oxygen uptake was also used as a way to measure 
exercise tolerance. 
 The 1
st
 study [Wasserman] was conducted throughout the United States at many different 
facilities. Every site abided by a workout protocol on either a bike or a treadmill. Baseline and 6 month 
protocols were the same. The 2
nd
 study [Conraads] is a European study that utilized a rigorous 
endurance training protocol for the CRT with ET and not training protocol for CRT without ET. There 
were baseline and 5 month measurements in this study. The 3
rd
 study [Schlosshan] is a crossover study 
conducted in Europe. Patients were evaluated with CRT either on or off and then on a separate day 
evaluated again with their CRT setting changed to the opposite setting. The 4
th
 study [Lavenezia] is a 
crossover study conducted in Canada. This study was a three days study with the first day being part of 
the learning curve and days 2 – 3 generating the results. Pt's were randomized to CRT on or off and 
switched the next day to the opposite setting. Pt were tested under incremental cycle exercising. 
 Key words used in searches were: CRT (cardiac resynchronization therapy), LVEF (left 
ventricular ejection fraction), peak VO2, NYHA (new york heart association), BVP (bi-ventricular 
pacing), CHF (congestive heart failure), CPET (cardiopulmonary exercise testing), LVF (left 
ventricular failure), AT (anaerobic threshold). All articles were published in peer review journals in 
English. Articles were found using Ovid and Cochrane databases and were chosen based on relevant 
and patient oriented evidence. Articles included were from 2007 or later due to a pending review in 
2006. All articles were RCTs and investigator blinded. 
 
 
 Table 2: Demographics 
Study Type #Pts Age (yrs) Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventio
ns 
Wasserman
, USA, 
2007 
Investigato
r Blinded 
RCT 
239 60-80 NYHA Class II-
IV LVF pts with 
wide (>120ms) 
QRS complexes 
and w/o BVP 
NYHA class I 
with narrow 
QRS complex 
0 (18 
crossed 
over from 
BVP-OFF 
to BVP-ON 
Randomize
d to BVP-
ON or BVP  
OFF 
Conraads, 
Europe, 
2007 
Investigato
r Blinded 
RCT 
17 50-68 Ischaemic or 
dilated 
cardiomyopathy
; NYHA > III; 
LVEF < 35%; 
LVEDD > 
55mm; LBBB > 
120ms; 
permanent sinus 
rhythm 
< 1 month 
stable 
pharmacologi
cal drug 
treatment; 
minimal 
inter-
ventricular 
dyssynchrony 
0 Randomize
d to CRT 
(+) 
[w/exercise 
training] or 
CRT (-) 
[w/o 
exercise 
training] 
Schlosshan
, Europe, 
2009 
Randomize
d Double 
Blind 
Crossover 
Trial 
15 54 - 72 Before CRT: 
NYHA > III, 
QRS > 120, 
LVEF < 35% 
After CRT: 
NYHA I – III (ie 
symptomatic 
benefit from 
CRT) 
Inability to do 
treadmill, 
exercise 
beyond 
anaerobic 
threshold, 
angina, 
coexisting 
lung, other 
systemic 
diseases 
0 CRT ON or 
OFF (order 
pt did the 
test on or 
off was 
blinding 
since it was 
a 
crossover) 
Lavenezian
a, Europe, 
2009 
Randomize
d Double 
Blind 
Crossover 
Trial 
7 69-73 CRT > 6m; 
NYHA III – IV; 
LVEF < 35%; 
QRS > 120ms 
Major 
cardiovascula
r event in 
previous 6w, 
HF needing 
continuous IV 
TX, resting 
O2 < 90% or 
4% decrease 
during 
exercise, 
other illness / 
inability to 
perform 
exercise 
0 CRT ON or 
OFF (order 
pt did the 
test on or 
off was 
blinding 
since it was 
a 
crossover) 
 OUTCOMES MEASURED 
 The key outcome measured in 3 / 4 studies [Laveneziana excluded] was V02 (peak oxygen 
uptake). Peak oxygen uptake measures the patients maximum capacity to use and transport oxygen 
exercise. This measurement translates into the individuals physical fitness level. Another primary 
outcome [included by Wasserman, Schlosshan] was anaerobic threshold. Anaerobic threshold  marks 
exercise that is rigorous enough to trigger anaerobic metabolism. Both V02 and AT are essentiall 
POEMs (patient oriented evidence that matters) in that improving values for both indicate the pt is able 
to exercise longer and harder without pain or fatigue. 
 [Laveneziana] utilized dyspnea and pain ratings to characterize the effects of exercise and CRT 
therapy. Pain was rated using the Borg scale. Other secondary measurements included heart rate, 
ventilation ratio and exercise time. The importance of all these measurements is that they can all show 
in both a subjective and physiologic way the patients exercise tolerance.  
RESULTS 
 Three of the four studies were convertible into dichotomous data [except Conraads]. The study 
data were compiled with intention-to-treat analysis in all four studies. All patients who began the study 
finished it. 
 Wasserman et al reported a 28% risk reduction when CRT was turned on (with a number need to 
treat of 4). The p-value was 0.0001 with a paired t test. The relative risk reduction could not be 
measured since the CER was 0. 
 Laveneziana et al reported that both leg discomfort and dyspnea were higher in the CRT off 
group. The p-value was 0.05. RRR and ARR could not be calculated in this study. Data shows an 
average dypsnea / pain rating (borg units) for CRT-OFF and CRT-ON but does not specify an n value. 
Pts were repeatedly used but randomized as to whether thy were receiving CRT for each exercise 
session. 
 Schlosshan et al showed that CRT-on during exercise led to an 8% improvement in exercise 
time and a 9% improvement in aerobic capacity. The p-value was 0.04 and 0.01 respectively. RRR and 
ARR could not be calculated in this study. The results show data averages +- deviations. 
 Conraads et al showed the CRT therapy plus exercise translated to a synergistic effect on V02 
increase. The p-value was 0.00003. Breath-by-breath gas exchange measurements were performed 
using a metabolic cart. Ventilation (VE) oxygen uptake (V02) and carbon dioxide production VC02) 
were determined on-line every 15s resulting in continuous data that could not be transformed into 
dichotomous data. 
Table 3: Dichotomous Results 
Study CER EER RBI ABI NNT P Value 
Wasserman 0.00% 28.00% NA 28.00% ~4 0.0001 
 Table 3 shows the results of calculations to determine benefit increases. Of the results, only one 
area of data was significantly significant. Only that data was included in the calculation. 54 of 192 
individuals who were evaluated with CRT on showed a statistically significant improvement in their 
peak VO2. Those 54 individuals started with a baseline VO2 of < 50% expected. There was no 
statistically significant data in the CRT off group resulting in n=0 for those with improved VO2. 
Consequently, the relative benefit increase cannot be calcuated due to a CER of 0. Likewise the 
anaerobic threshold improved in 40% of those with CRT on (p-value 0.0001) and could not be 
evaluated in CRT off due to a lack of  statistical significance (study records 28% of persons improved). 
Table 4: Lavenezia Results 
POEM CRT On CRT Off 
Dyspnea 2.7 +- 0.9* 4.6 +- 1.2 
Leg Discomfort 4.7 +- 1.1* 6.7 +- 0.7 
* P < 0.05 
 Table 4 shows the POEM results of the lavenezia et al study. Utilizing the Borg scale (0 no 
breathlessness – 10 max breathlessness) pt rated their dyspnea and leg discomfort while at rest, each 
minute of exercise and at peak exercise. A trend that can be noticed is CRT on values are often 
associated with statistical significance while CRT off values are not. Table 4 shows this trend. Both 
CRT on result in lower borg scale ratings (ie less dyspnea and leg discomfort) then CRT off. Lavenezia 
et al also measured value shared by the other studies such as VO2, pulse, etc... The results of these 
other parameters show general improvement when CRT was set to on. 
Table 5: Schlosshan Results 
POEM CRT On CRT Off P Value 
VO2 17.2 +- 4.9 15.6 +- 4.3 0.005 
Exercise Time 587 +- 212 542 +- 204 0.04 
 
 Table 5 shows the results of the Schlosshan et al study. Both V02 and exercise time were 
statisticall significant and showed improvement in those who had CRT set to on. Because this was a 
crossover study there were no n values assigned. Like the other studies, there were multiple parameters 
measured, however VO2 and exercise time are the most compatible when using as comparison to the 
other studies. 
 The Conraads et al study compared 4 groups of individuals to compare CRT with exercise and 
pharmacology, CRT with pharmacology, exercise and pharmacology and pharmacology alone. The 
study shows that the combination of CRT, exercise and pharmacology together resulted in the best 
outcome when measuring V02. CRT with pharmacology and pharmacology with exercise were similar 
in result. Pharmacology alone proved to be the least effective treatment protocol. VO2 measured at 
baseline and post the endurance training timeline. 
 The number needed to harm has not been calculated in this paper for the reason that we are 
examining the synergistic effects of exercise when combined CRT therapy. Both therapies are 
inherently safe (aside from the complications of the implanting the pacer) are not known for causing 
harm. The purpose of this paper was to emphasize the clinical importance of utilizing both therapies 
when treating heart failure patients. 
DISCUSSION 
 There are many therapies for heart failure, however there is a lack of evidence for definitive 
treatments aside from cardiac transplant. Therapies aim to accomplish two big task in the heart failure 
patient: prevent remodelling of the heart, improve ADLs. While we have taken a closer look at the pt's 
ADLs (ie POEMs) its important to remember that the studies do mention there appears to be 
improvement in the prevention of remodeling, though more studies are needed. CRT therapy aids the 
CHF patient by synchronizing the ventricles to work together providing stronger and more efficient 
contractions. Increased efficiency translates to better oxygenation throughout the body and therefore 
less cardiac demand. The results in less stress by the heart and a reduction in remodeling. Exercise in a 
normal healthy individual improves all of the different parameters we have studies in this paper such as 
VO2, exercise time, etc... With CRT therapy, even a heart failure pt can gain the full effects of exercise 
that a healthy heart can.  
 There are limitations to this review. The parameters between utilized RCTs vary, however they 
all point to the same generalized concept of exercise ability. Unfortunately evidence must be repeatable  
and better conclusions could be drawn with RCTs operating under the same study design. Population 
size was another limitation to the studies. For example [Conraads] represented 17 individuals. The 
results perhaps would have more statistical significance given a bigger set of individuals. CRT on is 
often statistically significant in the studies whereas CRT off is not. Consequently CRT off is usally the 
smaller subset such as in [Wasserman] where 192 were set to CRT on and 47 to CRT off. The condition 
of the pt entering the study may also play a role in how much of an impact the therapies have to offer. 
For example [Wasserman] deduces that those with a baseline V02 < 50% of the expected value seemed 
to benefit the most from the therapies. In future studies it might be beneficial to categorize the pts with 
a little more rigger rather then just NYHA classifications. [Conraads] pointed out that their study may 
have suffered from bias since they utilized data from a different trial and evaluated it while looking at a 
different variable. 
CONCLUSION 
  Cardiac resynchronization therapy and aerobic exercise does improve exercise tolerance / 
ability in heart failure patients better then either intervention alone. More study is needed to evaluate 
the best exercise regimen for the heart failure pt and also which type of heart failure patients benefit the 
most from a combination CRT / exercise regimen.  
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